← Back to Company DatabaseVisit Website
Paige
AI-powered digital pathology for cancer diagnosis.
Series C+New York, NYFounded 2017
About
Paige is a clinical AI company focused on transforming cancer diagnosis through computational pathology. Its FDA-approved AI products help pathologists detect cancer in tissue slides with greater accuracy and efficiency. The technology was developed from research at Memorial Sloan Kettering Cancer Center.
Total Funding
$250MKey Product
Paige Prostate AI pathology detectionGeography
North AmericaKey Investors
Goldman SachsHealthcare VenturesMemorial Sloan Kettering
Focus Areas
DiagnosticsAI / Machine Learning
Technology
AI / Machine LearningImaging / RadiologyDigital Health / Software
Cancer Types
ProstateBreastPan-cancer
Last updated: Feb 4, 2026